| # | Drug | Count |
|---|---|---|
| 0 | FREMANEZUMAB-VFRM | 45 |
| 1 | SECUKINUMAB | 25 |
| 2 | EPINEPHRINE | 19 |
| 3 | OFATUMUMAB | 8 |
| 4 | LISINOPRIL | 4 |
| 5 | METFORMIN | 3 |
| 6 | METFORMIN ER 500 MG | 3 |
| 7 | METFORMIN ER 750 MG | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FREMANEZUMAB-VFRM | 45 | 0.0038 |
| 1 | CHOLESTERINUM | 1 | 0.0009 |
| 2 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 3 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 | 0.0004 |
| 4 | EPINEPHRINE | 19 | 0.0003 |
| 5 | OFATUMUMAB | 8 | 0.0002 |
| 6 | SECUKINUMAB | 25 | 0.0002 |
| 7 | ZOLMITRIPTAN | 1 | 0.0001 |
| 8 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 9 | TIOTROPIUM BROMIDE INHALATION SPRAY | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 25 |
| 1 | Catecholamine [EPC] | 19 |
| 2 | alpha-Adrenergic Agonist [EPC] | 19 |
| 3 | beta-Adrenergic Agonist [EPC] | 19 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 6 | Loop Diuretic [EPC] | 3 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| 8 | Atypical Antipsychotic [EPC] | 2 |
| 9 | Corticosteroid [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 25 | 0.0007 |
| 1 | Catecholamine [EPC] | 19 | 0.0002 |
| 2 | Bile Acid [EPC] | 1 | 0.0000 |
| 3 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 8 | 0.0000 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Expectorant [EPC] | 2 | 0.0000 |